Kry Cuts EBITDA Burn 70%
Kry
The main signal is that Kry stopped acting like a land grab startup and started acting like a scaled care operator. The improvement came from cutting local overhead, exiting weaker markets, and pushing more patient volume through the same clinical and software infrastructure. That matters because telehealth has usually failed when fast growth depended on ever larger staff and marketing spend, but Kry showed it could keep growing while making each market work with tighter costs.
-
The cost reset was concrete. Kry reorganized in 2022, laid off about 400 employees, withdrew from Germany, and refocused on core markets. Management also said it replaced separate local teams with cross market functional teams, which lowered healthcare and operating costs while preserving growth.
-
The path to profitability also reflects scale advantages in public healthcare contracts. Kry said smaller telehealth rivals no longer had the scale to serve public and private payers profitably, while demand was concentrating toward larger stable vendors. In practice, that means the same app, care workflows, and payer integrations can support more visits without rebuilding the company country by country.
-
This looks stronger when compared with the broader sector. Kry had already posted $123M of losses on $164M of revenue in 2021, but many telehealth peers were even deeper underwater, including Teladoc, One Medical, and Oak Street. Kry’s hybrid model, digital visits plus clinics plus payer contracts, gave it more levers to improve unit economics than pure video visit businesses.
From here, profitability is likely to come from making Kry a denser network rather than a bigger org chart. More of the upside sits in routing patients through shared digital intake, AI assisted admin, and capitated payer contracts, so each additional consultation carries less overhead and makes Kry harder to displace inside European public healthcare systems.